LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia
Janani Ravikrishnan(The Ohio State University), Deepa Sampath(The University of Texas MD Anderson Cancer Center), Xiaokui Mo(The Ohio State University), Gerard Lozanski(The Ohio State University), Nitin Jain(Parul University), John R. Sanchez(The University of Texas MD Anderson Cancer Center), Rosa Lapalombella(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Stephen P. Anthony, Fenlai Tan(Betta Pharmaceuticals (China)), Mary C. Collins(Dana-Farber Cancer Institute), Elizabeth J. Perry(The Ohio State University), Suresh Satpati(The University of Texas MD Anderson Cancer Center), Seema A. Bhat(The Ohio State University), Matthew S. Davids(Dana-Farber Cancer Institute), Arletta Lozanski(The Ohio State University), Shrilekha Misra(The Ohio State University), Yue Shen(University of Illinois Urbana-Champaign), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Andrew D. Mitchell(University College London), Charmelle D. Williams(The University of Texas MD Anderson Cancer Center), Yi Chen(Sichuan University of Arts and Science), Yu Chen, Chaomei Liu(The University of Texas MD Anderson Cancer Center), Daisy Y. Diaz-Rohena(The University of Texas MD Anderson Cancer Center), Jennifer A. Woyach(The Ohio State University), Tierney Kaufman(The Ohio State University), KerryA Rogers(The Ohio State University), William G. Wierda(The University of Texas MD Anderson Cancer Center), John C. Byrd(University of Cincinnati), Tzung-Huei Lai(The Ohio State University), Elizabeth M. Muhowski(The Ohio State University)
Cited by 12
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k